Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,482 across all filing types
Latest filing 2023-09-26 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 25 September 2023.
Director's Dealing Classification · 100% confidence The document text explicitly contains the heading "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions (Sell) involving a person discharging managerial responsibilities (or closely associated) and the issuer (Sopharma AD). This structure and content directly correspond to regulatory filings reporting insider trading activities, which are classified as Director's Dealing (DIRS) in the provided schema, as it specifically covers 'Report of personal share transactions by company directors and executives (insider trades)'. The document is a detailed report, not just an announcement of a report.
2023-09-26 English
Notification from Simeon Donev under Art. 19 of Regulation (EU) No 596/2014 of 25 September 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving a 'person discharging managerial responsibilities' (Simeon Donev) concerning shares/warrants of an issuer ('Sopharma AD'). It specifies the nature of the transaction ('Buy') and the instrument details (Warrants, ISIN). This structure is characteristic of mandatory insider trading disclosures, specifically reporting personal share transactions by directors and executives. This aligns directly with the definition for Director's Dealing (DIRS).
2023-09-26 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 25 September 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving a 'person discharging managerial responsibilities' (Ognian Donev, Executive director and chairman of the Board of directors of Sopharma AD) concerning the purchase ('Buy') of financial instruments (Warrants). This structure, including fields for Name, Position, Issuer details, and specific transaction details (Price, Volume, Nature of transaction), is characteristic of mandatory insider trading disclosures required under regulations like MAR (Market Abuse Regulation) in the EU. Among the provided codes, 'Director's Dealing' (DIRS) specifically covers reports of personal share transactions by company directors and executives (insider trades).
2023-09-26 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 25 September 2023.
Director's Dealing Classification · 100% confidence The document text explicitly contains a section titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions (Buy) made by a person discharging managerial responsibilities (Ognian Donev, Executive director and chairman of the Board of directors) in the shares of Sopharma AD. This structure and content directly correspond to the definition of Director's Dealing (insider trades) reports.
2023-09-26 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 September 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving a 'person discharging managerial responsibilities' (Ognian Donev) and a 'person closely associated' (Donev Investments Holding AD) concerning financial instruments ('Warrants') of 'Sopharma AD'. Specifically, it reports a 'Sell' transaction, including price and volume details. This structure and content are characteristic of mandatory insider trading disclosures, often required under regulations like MAR (Market Abuse Regulation) in the EU. Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate classification for reports of personal share transactions by company directors and executives (insider trades).
2023-09-25 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 September 2023.
Director's Dealing Classification · 100% confidence The document explicitly states in the title: "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". This regulation pertains to market abuse and specifically covers transactions conducted by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. Section 4 details the transaction, including the instrument (Shares), nature (Buy), price, and volume. This perfectly matches the definition of Director's Dealing (insider trades). Filing Code: DIRS.
2023-09-25 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.